{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:25:57Z","timestamp":1790515557899,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bulcan.2016.11.012","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T16:46:04Z","timestamp":1482165964000},"page":"30-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Ob\u00e9sit\u00e9 et cancer"],"prefix":"10.1016","volume":"104","author":[{"given":"H\u00e9l\u00e8ne","family":"Sala\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Merrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1292-6631","authenticated-orcid":false,"given":"St\u00e9phane","family":"Vignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2016.11.012_bib0315","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200\u00a0countries from 1975\u00a0to 2014: a pooled analysis of 1698\u00a0population-based measurement studies with 19\u00b72\u00a0million, participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0320","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional and national prevalence of overweight and obesity in children and adults 1980\u20132013: a systematic analysis","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0325","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0330","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0335","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and cancer: the role of dysfunctional adipose tissue","volume":"18","author":"van Kruijsdijk","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0340","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.lpm.2006.12.031","article-title":"\u00c9valuation du co\u00fbt associ\u00e9 \u00e0 l\u2019ob\u00e9sit\u00e9 en France","volume":"36","author":"Emery","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0345","series-title":"Enqu\u00eate nationale sur l\u2019ob\u00e9sit\u00e9 et le surpoids","author":"ObEpi-Roche 2012","year":"2012"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0350","series-title":"M\u00e9decine et chirurgie de l\u2019ob\u00e9sit\u00e9","author":"Basdevant","year":"2011"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0355","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0360","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22\u00a0specific cancers: a population-based cohort study of 5\u00b724\u00a0million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0365","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.24803","article-title":"Incident cancer burden attributable to excess body mass index in 30\u00a0European countries","volume":"126","author":"Renehan","year":"2010","journal-title":"Int J Cancer J Int Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0370","series-title":"Food, nutrition, physical activity, and the prevention of cancer: a global perspective","author":"Marmot","year":"2007"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations","volume":"1271","author":"Vucenik","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0380","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/CCM.0000000000000602","article-title":"The relationship among obesity, nutritional status, and mortality in the critically ill","volume":"43","author":"Robinson","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0385","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2016.66.4391","article-title":"Trends in obesity prevalence in adults with a history of cancer: results from the US national health interview survey, 1997\u00a0to 2014","volume":"34","author":"Greenlee","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0390","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1200\/JCO.2015.63.1440","article-title":"Recommendations for obesity clinical trials in cancer survivors: American Society of Clinical Oncology Statement","volume":"33","author":"Ligibel","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0395","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1200\/JCO.2015.61.1095","article-title":"Results of the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors","volume":"33","author":"Rock","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0400","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2015.06.014","article-title":"Incidence of metabolic risk factors among healthy obese adults","volume":"66","author":"Bell","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0405","first-page":"2942","article-title":"Expression of the Type 1\u00a0insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease","volume":"62","author":"Hellawell","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0410","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0415","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17\u00a0prospective studies","volume":"11","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0420","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/ijc.24202","article-title":"Circulating insulin-like growth factor (IGF) peptides and prostate cancer risk: a systematic review and meta-analysis","volume":"124","author":"Rowlands","year":"2009","journal-title":"Int J Cancer J Int Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0425","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0430","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/cncr.21866","article-title":"Association between adiponectin, insulin resistance, and endometrial cancer","volume":"106","author":"Soliman","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0435","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/jnci\/dji376","article-title":"Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study","volume":"97","author":"Wei","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 6","key":"10.1016\/j.bulcan.2016.11.012_bib0440","article-title":"Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1\u00a0alpha in human colorectal cancer","volume":"18","author":"Koda","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0445","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1196\/annals.1397.013","article-title":"Expression of leptin, leptin receptor, and hypoxia-inducible factor 1\u00a0alpha in human endometrial cancer","volume":"1095","author":"Koda","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0450","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjc.6602743","article-title":"Plasminogen activator inhibitor-1\u00a0as a potential marker for the malignancy of colorectal cancer","volume":"93","author":"Sakakibara","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0455","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2007.11.025","article-title":"Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer","volume":"108","author":"Steiner","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0460","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1\u00a0in 8377\u00a0breast cancer patients","volume":"94","author":"Look","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.rgmx.2013.11.002","article-title":"C-reactive protein level in morbidly obese patients before and after bariatric surgery","volume":"79","author":"Rojano-Rodr\u00edguez","year":"2014","journal-title":"Rev Gastroenterol Mexico"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0470","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10552-008-9212-z","article-title":"Associations of circulating C-reactive protein and interleukin-6\u00a0with cancer risk: findings from two prospective cohorts and a meta-analysis","volume":"20","author":"Heikkil\u00e4","year":"2009","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0475","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","article-title":"Inflammation and cancer: how hot is the link?","volume":"72","author":"Aggarwal","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0480","first-page":"937","article-title":"Systematic review of the association between circulating interleukin-6 (IL-6) and cancer","volume":"44","author":"Heikkil\u00e4","year":"2008","journal-title":"Eur J Cancer 1990"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0485","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"Group TEH and BCC","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0490","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0495","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-14-0252","article-title":"Progesterone action in breast, uterine, and ovarian cancers","volume":"54","author":"Diep","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0500","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/hmbci-2015-0022","article-title":"A weighty problem: metabolic perturbations and the obesity-cancer link","volume":"23","author":"O\u2019Flanagan","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0505","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0510","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0515","first-page":"637","article-title":"[Malnutrition in oncology: frequent symptoms, insufficiently detected and management]","volume":"96","author":"Antoun","year":"2009","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0520","first-page":"32","article-title":"Obesity in cancer survival","author":"Parekh","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0525","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10552-010-9618-2","article-title":"Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer","volume":"21","author":"Waalkes","year":"2010","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0530","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000335478","article-title":"Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study","volume":"81","author":"Barret","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0535","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0540","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.2015.61.6441","article-title":"Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database","volume":"34","author":"Renfro","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0545","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239\u00a0prospective studies in four continents","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0550","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3945\/ajcn.2010.29532","article-title":"Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival","volume":"92","author":"Buijs","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0555","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic criteria for malnutrition \u2013\u00a0an ESPEN Consensus Statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0560","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0565","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5468\/ogs.2015.58.5.359","article-title":"Preoperative hypoalbuminemia is a risk factor for 30-day morbidity after gynecological malignancy surgery","volume":"58","author":"Kim","year":"2015","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0570","first-page":"384","article-title":"Patient-generated subjective global assessment and classic anthropometry: comparison between the methods in detection of malnutrition among elderly with cancer","volume":"31","author":"Ara\u00fajo dos Santos","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0575","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1207\/s15327914nc5301_6","article-title":"Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA)","volume":"53","author":"Read","year":"2005","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0580","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/annonc\/mdu501","article-title":"Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?","volume":"26","author":"Gioulbasanis","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0585","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline","volume":"30","author":"Griggs","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0590","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/cncr.23416","article-title":"Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice","volume":"112","author":"Greenman","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0595","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1010635328299","article-title":"Are medical oncologists biased in their treatment of the large woman with breast cancer?","volume":"66","author":"Madarnas","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0600","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/028418601750071082","article-title":"Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area","volume":"40","author":"Poikonen","year":"2001","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0605","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/jnci\/87.5.361","article-title":"Obesity and therapy-related toxicity in patients treated for small-cell lung cancer","volume":"87","author":"Georgiadis","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0610","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1996.14.11.3000","article-title":"Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541","volume":"14","author":"Rosner","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.11.012_bib0615","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(05)67110-3","article-title":"Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index","volume":"366","author":"Colleoni","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bulcan.2016.11.012_bib0620","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.critrevonc.2012.06.003","article-title":"Features of cancer management in obese patients","volume":"85","author":"Hijazi","year":"2013","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116303484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116303484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T08:49:33Z","timestamp":1718959773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455116303484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0007455116303484"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.11.012","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ob\u00e9sit\u00e9 et cancer","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}